Methods, products and systems for prognosis of subjects suffering from multiple myeloma
Номер патента: EP4244626A1
Опубликовано: 20-09-2023
Автор(ы): Claudine Sharon Bonder, Craig Thomas Wallington-Beddoe, Lisa Michelle EBERT
Принадлежит: Central Adelaide Local Health Network Inc, University of Adelaide, University of South Australia
Опубликовано: 20-09-2023
Автор(ы): Claudine Sharon Bonder, Craig Thomas Wallington-Beddoe, Lisa Michelle EBERT
Принадлежит: Central Adelaide Local Health Network Inc, University of Adelaide, University of South Australia
Реферат: The present disclosure relates to methods, products and systems for the prognosis of subjects suffering from multiple myeloma. In certain embodiments, the present disclosure provides a method of prognosis for a subject suffering from multiple myeloma. The method comprises determining the level of desmoglein 2 (DSG2) in malignant plasma cells from the subject, wherein an increased level of DSG2 in the plasma cells is indicative of a poorer prognosis for the subject.
Methods, products and systems for prognosis of subjects suffering from multiple myeloma
Номер патента: AU2021378331A9. Автор: Claudine Sharon Bonder,Lisa Michelle EBERT,Craig Thomas Wallington-Beddoe. Владелец: Central Adelaide Local Health Network Inc. Дата публикации: 2024-06-20.